Abstract
Anti-programmed cell death 1 (PD-1) or anti-PD-ligand (L) 1 drugs, as classic immune checkpoint inhibitors, are considered promising treatment strateg......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
